Bo Kruse, EVP, CFO, SECRY & Treasurer at Y-mAbs Therapeutics, Inc. (YMAB), sold 120,000 shares at $12.07 ($1.4M) on 2024-05-31, disclosed to the SEC on 2024-05-31.
Open-market sale of $1.4M YMAB by EVP, CFO, SECRY & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.03 | 28,629 | $344K | 23.8% |
| 2 | $12.03 | 28,629 | $344K | 23.8% |
| 3 | $12.07 | 31,371 | $379K | 26.2% |
| 4 | $12.07 | 31,371 | $379K | 26.2% |
| Total | $12.05 avg | 120,000 | $1.4M | 100% |
| Filing → |
| YMAB | SELL | 2022-01-25 | $39K | — | Filing → |
| YMAB | SELL | 2022-01-05 | $68K | — | Filing → |
| YMAB | SELL | 2021-12-23 | $65K | — | Filing → |